2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

506. Bone Marrow Microenvironment: Poster I

Program: Poster Abstract Session
Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Omics Technologies, Bioinformatics, Cell Expansion, Gene Editing, Profiling, Treatment Considerations, Biological Therapies, Transplantation, Immunotherapy, Biological Processes, Pathogenesis, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Clinical Practice (Health Services and Quality), Practice Models, Diseases, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, CML, Study Population, Human, Animal Model
PAPER

1387 UNC5A loss disrupts the bone marrow vascular niche and impairs hematopoiesis

Morgan Drew Donahoe, Bianca Elizabeth Bean, B.S.2, Cody William Carter, BS, MS3, Pradeep Ramalingam, MD PhD4, Jason Butler, Ph.D.5
1 University of Florida, Gainesville, Florida, United States
2 University of Florida, Gainesville, Florida, United States
3 University of Florida, Gainesville, Florida, United States
4 University of Florida, Gainesville, Florida, United States
5 University of Florida, Gainesville, Florida, United States

Hematopoietic stem cells (HSCs) sustain lifelong blood and immune cell production and are tightly regulated by the vascular niche, specifically by bone marrow endothelial cells (BMECs). We previously identified endothelial-derived Netrin-1 (NTN1) as a critical factor in HSC and niche integrity that declines with age. Endothelial-specific NTN1 knockout mice exhibit features of hematopoietic aging, displaying impaired vascular integrity, reduced HSC engraftment, and increased DNA damage, while administration of recombinant NTN1 reverses these aging phenotypes, repairs HSC DNA damage, and improves survival after serial myelosuppression. These findings establish NTN1 as a powerful rejuvenating signal within the aging niche.

We have recently demonstrated that NTN1 acts through the UNC5A receptor to preserve hematopoietic function. The phenotype of global UNC5A knockout mice (UNC5AgKO) is highly consistent with NTN1 loss in endothelium: reduced blood and femur counts, increased HSC frequency, elevated DNA damage, and impaired engraftment following competitive transplant. UNC5AgKO mice also fail to recover from sublethal myelosuppression, highlighting the importance of NTN1-UNC5A signaling for hematopoietic recovery following stress.

Reciprocal transplantation data suggests these HSC defects are intrinsic, but it remains unclear whether the global knockout of UNC5A impacts BMEC function. UNC5AgKO mice exhibit significantly enlarged femoral vessel diameter, yet vascular permeability, measured by Evan’s blue and 70kDa Dextran leakiness assays, is unchanged relative to controls, showing that UNC5A loss remodels vascular architecture without disrupting barrier integrity.

To further assess vascular function, we performed a scratch wound assay on BMECs isolated from control and UNC5AgKO mice. UNC5AgKO BMECs experienced significantly impaired wound closure compared with control BMECs (p=1.82×10-8). This suggests that loss of UNC5A impairs endothelial repair capacity.

Additionally, we utilized our laboratory’s BMEC/HSC co-culture assay to assess the capacity of UNC5AgKO BMECs to support ex vivo hematopoiesis. Hematopoietic stem and progenitor cells defined by cKit+Sca1+Lineage- (KLS) were co-cultured with either control or UNC5AgKO BMECs. Following 9 days, the frequency of expanded cells was assessed. Hematopoietic cells co-cultured with UNC5AgKO BMECs resulted in a greater than threefold reduction in the KLS population compared with control BMECs (p=0.0159). Additionally, the overall CD45+ population was significantly greater in the control condition than in UNC5AgKO (p=0.0443). To assess HSC function, we competitively transplanted 1×105 expanded CD45.2+ hematopoietic cells with 5×105 CD45.1+ hematopoietic cells. We found that hematopoietic cells expanded on UNC5AgKO BMECs resulted in a significant decrease in long-term engraftment. These findings suggest that BMECs from UNC5AgKO mice have a compromised ability to sustain and expand hematopoietic stem and progenitor cells.

Together, these findings identify UNC5A as a critical regulator of both vascular and hematopoietic function in the bone marrow niche in maintaining vascular architecture and endothelial repair capacity, while also enabling BMECs to support HSC function. Therefore, the hematopoietic failure observed in UNC5AgKO mice reflects a combined breakdown of HSC-intrinsic and niche-derived signaling, not HSC dysfunction alone. By defining NTN1-UNC5A as a targetable signaling pathway linking vascular health to hematopoietic aging, this work explores a therapeutic avenue for rejuvenating the aging bone marrow niche and restoring hematopoietic resilience in aging, transplantation, and myelosuppressive therapy.

Morgan Drew Donahoe: No relevant conflicts of interest to declare.